Frequency of diabetic retinopathy and its severity in type 2 diabetic patients with microalbuminuria
DOI:
https://doi.org/10.59736/IJP.23.04.977Keywords:
Diabetic Retinopathy,, Endothelial Dysfunction, Glycemic Control, Microalbuminuria, Type 2 Diabetes MellitusAbstract
Background: Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM) and a leading cause of vision loss. Microalbuminuria, an early marker of nephropathy, reflects generalized microvascular injury and may predict higher DR risk. This study aimed to determine the frequency of DR in T2DM patients with microalbuminuria.
Methods: A comparative cross-sectional study was conducted at Qazi Hussain Ahmad Medical Complex, Nowshera, over 6 months. A total of 1,300 T2DM patients were screened for microalbuminuria by urine immunoturbidimetric assay. Patients with microalbuminuria (n=381) formed the study group, while an equal number of diabetics without microalbuminuria (n=381) served as controls. Exclusion criteria included prior retinal laser treatment, overt proteinuria or nephropathy of other etiology, and uncontrolled hypertension. All participants underwent detailed ophthalmic examination including fundoscopy by a consultant ophthalmologist. DR was graded as present or absent based on characteristic retinal lesions. Statistical analysis was performed using SPSS 25; Chi-square test determined associations, with p<0.05 significant. Results: Of 1,300 screened, 29.3% (381) had microalbuminuria. Their mean age was 52.4 ± 9.8 years, mean diabetes duration 10 ± 6 years, and 55% were male. DR was detected in 45.4% (173/381) of microalbuminuric patients compared with 24.3% (93/381) of normoalbuminuric controls (p<0.001). The relative risk of DR with microalbuminuria was 1.87 (95% CI 1.54–2.27). Vision-threatening DR occurred in 18% of the microalbuminuria group versus 7% of controls (p=0.002). Patients with microalbuminuria also had higher HbA1c (8.9% vs 8.1%, p=0.01) and longer diabetes duration (12 vs 8 years, p<0.001).
Conclusion: Microalbuminuria is strongly associated with DR and may serve as a clinical indicator for heightened retinopathy risk. Regular ophthalmologic screening and improved glycemic control are essential in this high-risk subgroup.
References
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes: global burden of disease and forecasted trends. J Epidemiol Glob Health. 2019; 10:107. doi:10.2991/jegh.k.191028.001
Ranasinghe P, Rathnayake N, Wijayawardhana S, Jeyapragasam H, Meegoda VJ, Jayawardena R, et al. Rising trends of diabetes in South Asia: a systematic review and meta-analysis. Diabetes Metab Syndr. 2024; 18:103160. doi: 10.1016/j.dsx.2024.103160
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271–81. doi: 10.1016/j.diabres.2018.02.023
Baumal CR, Spaide RF, Vajzovic L, Freund KB, Walter SD, John V, et al. Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab. Ophthalmology. 2020; 127:1345–59. doi: 10.1016/j.ophtha.2020.04.017
Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF Diabetes Atlas: a review of studies utilizing retinal photography on the global prevalence of diabetes-related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019; 157:107840.doi:10.1016/j.diabres.2019.107840
Hashemi H, Rezvan F, Pakzad R, Ansaripour A, Heydarian S, Yekta A, et al. Global and regional prevalence of diabetic retinopathy: a comprehensive systematic reviewandmetaanalysis.SeminOphthalmol.2022;37:291–306. doi:10.1080/08820538.2021.1962920
Feng RF, Liu YL, Xu Q, et al. Diabetes onset at an earlier age and high HbA1c levels as risk factors of diabetic retinopathy. Int J Ophthalmol. 2021; 14:269–76. doi:10.18240/ijo.2021.02.14
Narayan KMV, Kondal D, Daya N, Gujral UP, Mohan D, Patel SA, et al. Incidence and pathophysiology of diabetes in South Asian adults living in India and Pakistan compared with US blacks and whites. BMJ Open Diabetes Res Care. 2021;9: e001927. doi:10.1136/bmjdrc-2020-001927
Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017; 12:2032–45. doi:10.2215/CJN.11491116
Mohammed O, Alemayehu E, Bisetegn H, Debash H, Gedefie A, Ebrahim H, et al. Prevalence of microalbuminuria among diabetes patients in Africa: a systematic review and meta-analysis. Diabetes Metab SyndrObes.2023;16:2089–103. doi:10.2147/DMSO.S409483
Lin X, Song W, Zhou Y, Gao Y, Wang Y, Wang Y, et al. Elevated urine albumin–creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study. Cardiovasc Diabetol. 2023; 22:203. doi:10.1186/s12933-023-01907-3
Lehner Z, Stadlbauer K, Brunmair B, Adorjan I, Genov M, Kautzky-Willer A, et al. Evidence that the multiflorine-derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α2-adrenoceptors in mice. Diabetes Obes Metab.2020;22:290–302. doi:10.1111/dom.13895
Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 2021; 42:29–55. doi:10.1210/endrev/bnaa025
Qirjazi E, Salerno FR, Akbari A, Hur L, Penny J, Scholl T, et al. Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging. Nephrol Dial Transplant. 2021; 36:1234–43. doi:10.1093/ndt/gfaa036
Fang J, Luo C, Zhang D, He Q, Liu L. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study. Front Endocrinol.2023;14: 1265711.doi:10.3389/fendo.2023.1265711
Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011; 29:1802–9. doi: 10.1097/HJH.0b013e3283495cd6
Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, et al. Impact of physical activity and sedentary time on glycated hemoglobin levels and body composition: cross-sectional study using outpatient clinical data of Japanese patients with type 2 diabetes. J Diabetes Investig.2020;11:633–9. doi:10.1111/jdi.13185
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35:556–64. doi:10.2337/dc11-1909
Asghar S, Asghar S, Mahmood T, Bukhari SMH, Mumtaz MH, Rasheed A. Microalbuminuria as the tip of the iceberg in type 2 diabetes mellitus: prevalence, risk factors, and associated diabetic complications. Cureus. 2023;15: e43190. doi:10.7759/cureus.43190
Gerstein HC. Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Int J Clin Pract Suppl. 2001;(117):8–12.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mohammad Bilal, Muhammad Usman, Naeem Khan, Kalim Ullah Khan, Adul Hanan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
